首页> 美国卫生研究院文献>Nanoscale Research Letters >A pH-Induced Reversible Assembly System with Resveratrol-Controllable Loading and Release for Enhanced Tumor-Targeting Chemotherapy
【2h】

A pH-Induced Reversible Assembly System with Resveratrol-Controllable Loading and Release for Enhanced Tumor-Targeting Chemotherapy

机译:pH诱导的可逆装配系统白藜芦醇可控制的加载和释放用于增强靶向肿瘤的化学疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this report, we present a pH-induced reversible assembly system (PIRAS) based on ferritin (Ft) for targeted tumor therapy. It has been developed to easily load and release of the anticancer drug resveratrol (RV), based on its natural pH-sensitivity and unique hollow cavity of Ft. A tumor-specific target peptide Arg-Gly-Asp (RGD) was conjugated onto the surface of RV-loaded Ft (RV@Ft), to form biocompatible nanoparticles (RV@Ft-RGD). The pH-sensitivity of Ft allows it to be denatured into a hollow porous nanosphere under acidic condition and renatured into a sealed hollow nanosphere under neutral condition. Using pH manipulation, RV@Ft-RGD, with a ~ 21 nm diameter, showed a high RV loading ratio of 79.6%. pH-triggered RV release was then measured at a ratio of 50.3% at pH5.0 over 24 h. Under neutral condition, the RV@Ft-RGD showed excellent stability over 20 days. Confocal fluorescence imaging showed that RV@Ft-RGD had a high cell uptake ratio and co-localization with the lysosome, mainly due to the RGD-mediated target effect. Based on the high drug loading, pH-triggered release, and tumor cell targeting effect, RV@Ft-RGD showed great cell-killing ability in vitro and in vivo. The biocompatibility in vitro and in vivo was also demonstrated to be excellent, without systematic toxicity. The design concept of PIRAS based on Ft significantly inhibits tumor growth and simultaneously further broadens the application of Ft in nanomedicine.Electronic supplementary materialThe online version of this article (10.1186/s11671-019-3139-z) contains supplementary material, which is available to authorized users.
机译:在本报告中,我们提出了一种基于铁蛋白(Ft)的pH诱导可逆组装系统(PIRAS),用于靶向肿瘤治疗。由于其天然的pH敏感性和独特的Ft空腔,已开发出可轻松加载和释放抗癌药物白藜芦醇(RV)的产品。将肿瘤特异性靶肽Arg-Gly-Asp(RGD)偶联到负载RV的Ft(RV @ Ft)的表面上,以形成生物相容性纳米粒子(RV @ Ft-RGD)。 Ft的pH敏感性使其可以在酸性条件下变性为空心多孔纳米球,并在中性条件下变性为密封的空心纳米球。使用pH操纵,直径约21 nm的RV @ Ft-RGD表现出79.6%的高RV负载率。然后在24小时内,在pH5.0下以50.3%的比率测量了由pH触发的RV释放。在中性条件下,RV @ Ft-RGD在20天内表现出出色的稳定性。共聚焦荧光成像显示RV @ Ft-RGD具有较高的细胞摄取率,并且与溶酶体共定位,这主要是由于RGD介导的靶标作用。基于高载药量,pH触发释放和肿瘤细胞靶向作用,RV @ Ft-RGD在体外和体内均显示出强大的细胞杀伤能力。在体外和体内的生物相容性也被证明是极好的,没有系统毒性。基于Ft的PIRAS的设计理念显着抑制了肿瘤的生长,同时进一步拓宽了Ft在纳米医学中的应用。电子补充材料本文的在线版本(10.1186 / s11671-019-3139-z)包含补充材料,可用于授权用户。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号